2007
DOI: 10.1186/1471-2229-7-26
|View full text |Cite
|
Sign up to set email alerts
|

Saccharomyces cerevisiae FKBP12 binds Arabidopsis thaliana TOR and its expression in plants leads to rapamycin susceptibility

Abstract: Background: The eukaryotic TOR pathway controls translation, growth and the cell cycle in response to environmental signals such as nutrients or growth-stimulating factors. The TOR protein kinase can be inactivated by the antibiotic rapamycin following the formation of a ternary complex between TOR, rapamycin and FKBP12 proteins. The TOR protein is also found in higher plants despite the fact that they are rapamycin insensitive. Previous findings using the yeast two hybrid system suggest that the FKBP12 plant … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
121
0
4

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(132 citation statements)
references
References 38 publications
7
121
0
4
Order By: Relevance
“…The severity of these phenotypes increased with increasing concentrations of rapamycin, with even a dose of 0.5 µg/mL rapamycin being sufficient to observe effects on seedling growth in all the four BP12 lines ( Figure 1D). These results clearly indicate that Arabidopsis seedling growth and the observed root and shoot phenotypes are dependent on both the FKBP12 transgene expression and rapamycin, consistent with previous observations (Mahfouz et al, 2006;Sormani et al, 2007;Leiber et al, 2010). We would like to note here that compared with the findings with transgenic Arabidopsis lines, the wild-type seedling growth was normal even at the highest concentration of rapamycin tested (i.e., 20 µg/mL medium) ( Figure 1D).…”
supporting
confidence: 80%
See 1 more Smart Citation
“…The severity of these phenotypes increased with increasing concentrations of rapamycin, with even a dose of 0.5 µg/mL rapamycin being sufficient to observe effects on seedling growth in all the four BP12 lines ( Figure 1D). These results clearly indicate that Arabidopsis seedling growth and the observed root and shoot phenotypes are dependent on both the FKBP12 transgene expression and rapamycin, consistent with previous observations (Mahfouz et al, 2006;Sormani et al, 2007;Leiber et al, 2010). We would like to note here that compared with the findings with transgenic Arabidopsis lines, the wild-type seedling growth was normal even at the highest concentration of rapamycin tested (i.e., 20 µg/mL medium) ( Figure 1D).…”
supporting
confidence: 80%
“…Rapamycin specifically binds to FKBP12 (for FK506 binding protein 12), which interacts with the FRB domain of TOR, and the resultant rapamycin-FKBP12-TOR inhibitory complex renders the TOR pathway inactive (Heitman et al, 1991;Stan et al, 1994;Zheng et al, 1995;Loewith et al, 2002). Studies with Arabidopsis have shown that rapamycin treatment does not produce phenotypes associated with inhibition of TOR, and this is attributed to structural differences of the target Arabidopsis FKBP12 proteins, which are unlike their yeast or mammalian counterparts (Xu et al, 1998;Menand et al, 2002;Sormani et al, 2007). This is further supported by studies that showed that transgenic Arabidopsis plants that expressed yeast or human FKBP12 proteins are rapamycin sensitive Leiber et al, 2010;Xiong and Sheen, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…However, the FKBP12 gene does render TOR sensitive to rapamycin, as long as FKBP12 is expressed at a sufficient level (Xiong and Sheen, 2012). Cereals are also sensitive to the drug (Agredano-Moreno et al, 2007;Schepetilnikov et al, 2011), and Arabidopsis TOR becomes more sensitive to rapamycin when a human or yeast FK506 binding protein is expressed in Arabidopsis (Mahfouz et al, 2006;Sormani et al, 2007;Ren et al, 2012). Arabidopsis TOR is also sensitive to the novel mammalian TOR inhibitor, Torin1 (Schepetilnikov et al, 2013).…”
Section: Tor Kinasementioning
confidence: 99%
“…Arabidopsis TOR displays a weak sensitivity to the peptidyl-prolyl cis/trans isomerase (FK506-binding protein 12 [FKBP12])-rapamycin complex (Menand et al, 2002;Sormani et al, 2007), or becomes sensitive when human or yeast FKBP12 is overexpressed in Arabidopsis or high rapamycin concentrations are applied to inhibit growth (Mahfouz et al, 2006;Sormani et al, 2007;Ren et al, 2012;Xiong and Sheen, 2012). Currently, ATP-competitive inhibitors such as Torin-1 and the second-generation inhibitor AZD-8055 are used widely to block TOR in plants (Montané and Menand, 2013;Schepetilnikov et al, 2013Schepetilnikov et al, , 2017.…”
Section: Plant Tor Complex Compositionmentioning
confidence: 99%